Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03275805 · ClinicalTrials.gov registry record · NA
Should Graf IIc Hips be Treated for 12 Weeks
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03275805 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 20 participants.
The verdict
NCT03275805, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Children who are diagnosed with Developmental Hip Dysplasia (DDH) are often categorized depending on the severity of their hip malformation. Regardless of the severity, the accepted form of treatment is the Pavlik Harness. Unfortunately, there is no specific recommended treatment regarding length of Pavlik Harness treatment for patients with DDH who have who have been categorized with stable Graf type IIc hips. The investigators will aim to answer this question with a randomized controlled trial of patients with these specific findings by dividing selected patients into 2 arms. Each arm consists of varying lengths of Pavlik harness treatment (treatment to normalization, no less than 6 weeks or 12 weeks full-time). Patient's two year follow up radiographs will determine the best means of treatment.
Interventions
- OTHER Duration of Pavlik Harness treatment
- OTHER 12 week standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03275805
The ClinicalTrials.gov registry entry for NCT03275805 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Duration of Pavlik Harness treatment is the first listed.
NCT03275805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03275805 about?
NCT03275805 is a clinical study titled "Should Graf IIc Hips be Treated for 12 Weeks". Children who are diagnosed with Developmental Hip Dysplasia (DDH) are often categorized depending on the severity of their hip malformation. Regardless of the severity, the accepted form of treatment is the Pavlik Harness. Unfortunately, there is no specific recommended treatment regarding length of...
What is the current status of trial NCT03275805?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2021-06-11. Estimated completion is 2025-07-01.
What interventions are being tested in trial NCT03275805?
The interventions under investigation include: Duration of Pavlik Harness treatment (OTHER), 12 week standard of care (OTHER).
Who is sponsoring clinical trial NCT03275805?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.